journal article·2025-01-01Open access

RCAN1.4 regulates tumor cell engraftment and invasion in a thyroid cancer to lung metastasis-on-a-chip microphysiological system

Kylie G Nairon, Akanksha Nigam, Tilak Khanal, Marco A Rodriguez, Neel Rajan, Sydney R Anderson, Matthew D Ringel, Aleksander Skardal

Biofabrication· Volume 17· Issue 1

Abstract

Abstract Progressive metastasis is the primary cause of cancer-related deaths. It has been recognized that many cancers are characterized by long periods of stability followed by subsequent progression. Genes termed metastasis progression suppressors (MPS) are functional gatekeepers of this process, and their loss leads to late-stage progression. Previously, we identified regulator of calcineurin 1, isoform 4 (RCAN1.4) as a functional MPS for several cancers, including thyroid cancer, a tumor type prone to metastatic dormancy. RCAN1.4 knockdown increases expression of the cancer-promoting transcription factor NFE2-like bZIP transcription factor (NFE2L3), and through this mechanism increases cancer cell proliferation and invasion in in vitro and in vivo and promotes metastatic potential to lungs in tail vein models. However, the mechanisms by which RCAN 1.4 regulates specific metastatic steps is incompletely characterized. Studies of the metastatic cascade are limited in mouse systems due to high cost and long duration. Here, we have shown the creation of a thyroid-to-lung metastasis-on-a-chip (MOC) model to address these limitations, allowing invasion analysis and quantification on a single cell level. We then deployed the platform to investigate RCAN1.4 knockdown in fluorescently tagged hTh74 and FTC236 thyroid cancer cell lines. Cells were circulated through microfluidic channels, running parallel to lung hydrogel constructs allowing tumor cell-lung tissue interactions. Similar to studies in mouse models, RCAN1.4 knockdown increased NFE2L3 expression, globally increased invasion distance into lung constructs and had cell line and clonally dependent variations on bulk metastatic burden. In line with previous in vivo observations, RCAN1.4 knockdown had a greater impact on hTh74 metastatic propensity than FTC236. In summary, we have developed and validated a novel MOC system evaluate and quantify RCAN1.4-regulated thyroid cancer cell lung adherence and invasion. This system creates opportunities for more detailed and rapid mechanistic studies the metastatic cascade and creates opportunities for translational assay development.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Signaling Pathways in Disease · Neuropeptides and Animal Physiology · Mechanisms of cancer metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications10.1007/s12020-020-02453-8 ↗
2. Intravital imaging to study cancer progression and metastasis10.1038/s41568-022-00527-5 ↗
3. Genomic responses in mouse models poorly mimic human inflammatory diseases10.1073/pnas.1222878110 ↗
4. Trials, tribulations, and trends in tumor modeling in mice10.1080/01926230490424770 ↗
5. Lost in translation: animal models and clinical trials in cancer treatment
6. Evidence for a novel gene associated with low tumor metastatic potential10.1093/jnci/80.3.200 ↗
7. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene10.1093/jnci/88.23.1731 ↗
8. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13
9. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.210.1126/science.7754374 ↗
10. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma10.1007/s00428-008-0590-0 ↗
11. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer10.3892/or.2013.2558 ↗
12. Metastasis-suppressor genes in clinical practice: lost in translation?10.1038/nrclinonc.2011.65 ↗
13. RCAN1.4 regulatres VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells10.1007/s10456-017-9542-0 ↗
14. A new human gene from the down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart10.1093/hmg/4.10.1935 ↗
15. Down’s syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR110.1038/nature08062 ↗
16. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis10.1016/j.canlet.2013.08.047 ↗
17. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma10.1186/s12943-020-01236-z ↗
18. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor10.1038/35079135 ↗
19. Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells10.1210/jcem.87.5.8626 ↗
20. KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity10.1210/jc.2005-0963 ↗
21. Regulator of calcineurin 1 modulates cancer cell migration in vitro10.1007/s10585-009-9251-1 ↗
22. The RCAN1.4 metastasis suppressor is hypermethylated at intron 1 in thyroid cancer10.1089/thy.2022.0687 ↗
23. Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety. Lab on a chip10.1039/D0LC00424C ↗
24. Human induced pluripotent stem-cardiac-endothelial-tumor-on-a-chip to assess anticancer efficacy and cardiotoxicity10.1089/ten.tec.2019.0248 ↗
25. Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells10.1073/pnas.1209893109 ↗
26. Elucidating mechanical transition effects of invading cancer cells with a subnucleus-scaled microfluidic serial dimensional modulation device10.1039/C2LC41117B ↗
27. Development of a colorectal cancer 3D micro-tumor construct platform from cell lines and patient tumor biospecimens for standard-of-care and experimental drug screening10.1007/s10439-019-02269-2 ↗
28. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening10.1038/s41598-018-21200-8 ↗
29. Multi-domain photopatterned 3D tumor constructs in a micro-physiological system for analysis, quantification, and isolation of infiltrating cells10.1002/adbi.201900273 ↗
30. Patient-specific sarcoma organoids for personalized translational research: unification of the operating room with rare cancer research and clinical implications10.1245/s10434-022-12086-y ↗
31. Model of patient-specific immune-enhanced organoids for immunotherapy screening: feasibility study10.1245/s10434-019-08143-8 ↗
32. Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration10.1210/jc.2012-3937 ↗
33. RCAN1-4 is a thyroid cancer growth and metastasis suppressor10.1172/jci.insight.90651 ↗
34. Optimization of collagen type I-hyaluronan hybrid bioink for 3D bioprinted liver microenvironments10.1088/1758-5090/aae543 ↗
35. Mesenteric arteries responsiveness to acute variations of wall shear stress is imparied in rats with liver cirrhosis10.3109/00365521.2021.703231 ↗
36. Wall shear stress quantification in the human conjunctival pre-capillary arterioles in vivo10.1016/j.mvr.2012.11.003 ↗
37. Volume flow and wall shear stress quantification in the human conjunctival capillaries and post-capillary venules in vivo
38. Wall shear stress: theoretical considerations and methods of measurement10.1016/j.pcad.2006.11.001 ↗
39. A multi-site metastasis-on-a-chip microphysiological system for assessing metastatic preference of cancer cells10.1002/bit.26871 ↗
40. A 3D adrenocortical carcinoma tumor platform for preclinical modeling of drug response and matrix metalloproteinase activity10.1101/2023.01.24.525287 ↗
41. A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs10.1016/j.actbio.2015.07.030 ↗
42. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform10.1038/s41598-017-08879-x ↗
43. Roles of NRF3 in the hallmarks of cancer: proteasomal inactivation of tumor suppressors10.3390/cancers12092681 ↗
44. New addiction to the NRF2-related factor NRF3 in cancer cells: ubiquitin-independent proteolysis through the 20S proteasome10.1111/cas.14244 ↗
45. A 3D adrenocortical carcinoma tumor platform for preclinical modeling of drug response and matrix metalloproteinase activity10.1038/s41598-023-42659-0 ↗
46. Deconstructed microfluidic bone marrow on-a-chip to study normal and malignant hemopoietic cell-niche interactions10.1002/smll.201902971 ↗
47. Of mice and not men: differences between mouse and human immunology10.4049/jimmunol.172.5.2731 ↗
48. Tumor cell-conditioned media drives collagen remodeling via fibroblast and pericyte activation in an in vitro premetastatic niche model10.1016/j.isci.2022.104645 ↗
49. In situ deployment of engineered extracellular vesicles into the tumor niche via myeloid-derived suppressor cells10.1002/adhm.202101619 ↗
50. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening10.1002/bit.25950 ↗